báo cáo khoa học: "Correction: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors." pptx

This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Correction: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World Journal of Surgical Oncology 2011, 9:120 doi:10.1186/1477-7819-9-120 N. Ozlem Kucuk (csoydal@yahoo.com) Cigdem Soydal (csoydal@yahoo.com) Seda Lacin (csoydal@yahoo.com) Elgin Ozkan (csoydal@yahoo.com) Sadik Bilgic (csoydal@yahoo.com) ISSN 1477-7819 Article type Correction Submission date 5 October 2011 Acceptance date 6 October 2011 Publication date 6 October 2011 Article URL http://www.wjso.com/content/9/1/120 This peer-reviewed article was published immediately upon acceptance. It can be downloaded, printed and distributed freely for any purposes (see copyright notice below). Articles in WJSO are listed in PubMed and archived at PubMed Central. For information about publishing your research in WJSO or any BioMed Central journal, go to http://www.wjso.com/authors/instructions/ For information about other BioMed Central publications go to http://www.biomedcentral.com/ World Journal of Surgical Oncology © 2011 Kucuk et al. ; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Correction: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. N. Ozlem Kucuk¹, Cigdem Soydal¹, Seda Lacin¹, Elgin Ozkan¹, Sadık Bilgic² ¹ Ankara University, Medical School, Department of Nuclear Medicine, Ankara, Turkey. ² Ankara University, Medical School, Department of Radiology, Ankara, Turkey. *Corresponding author: csoydal@yahoo.com Correction After the publication of this work [1], we became aware of the fact that there was date mistakes in the Abstract, Patients and method and Results sections. The correct text is included below. In the ‘Methods’ section of the Abstract, the first sentence should have read: “The clinical and follow-up data of 124 patients who were referred to our department for SIRT between June 2006 and October 2010 were evaluated retrospectively.” In The ‘Patients’ section of the Patients and Method, the first sentence should have read: “The clinical and follow-up data of 124 patients who were referred to our department for SIRT between June 2008 and October 2010 were evaluated retrospectively.” In the ‘Patients’ section of the Results, the first sentence should have read: “78 patients (49 M; 29 F; mean age: 62.4+2.3 years) received intra-arterial radionuclide treatments with 90Y for liver metastasis or primary HCC between June 2008 and October 2010.“ References 1. N. Ozlem Kucuk, Cigdem SOYDAL, Seda Lacin et al. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World J Surg Oncol. 2011 Aug 6;9:86. . Fully formatted PDF and full text (HTML) versions will be made available soon. Correction: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary. Seda Lacin et al. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors. World J Surg Oncol. 2011 Aug 6;9:86 distribution, and reproduction in any medium, provided the original work is properly cited. Correction: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary